Lianhe Aigen is a leading Contract Research Organization (CRO) services provider, specializing in preclinical new drug discovery and development. Our Shanghai-based R&D center is dedicated to offering innovative solutions that support global pharmaceutical companies throughout the drug discovery process, from initial research to preclinical testing. As a trusted CRO partner, we are committed to helping you accelerate your drug development pipeline with high-quality, scientifically robust services tailored to meet your specific needs.

Why Choose Our CRO Services?

With over a decade of experience in the pharmaceutical industry, Lianhe Aigen has built a reputation for excellence in providing comprehensive CRO services. Our advanced capabilities and cutting-edge technologies ensure we can support your drug discovery programs with precision, efficiency, and flexibility, ultimately driving your product toward regulatory approval and market success.

Key Features of Our CRO Services:

1. Comprehensive Drug Discovery Support:

Full-spectrum preclinical services, including hit identification, lead optimization, and candidate selection.

Early-stage discovery services for small molecules, peptides, and biologics, utilizing state-of-the-art tools and platforms.

2. Advanced Research and Development Platforms:

R&D Technology Innovation Platform for drug design and optimization.

Flow Chemistry and Solid-State Chemistry platforms for efficient synthesis and screening.

Targeted platforms for Amino Acids & Peptides, ADC/PROTAC Linkers, and Oligonucleotides.

3. Regulatory Expertise and Global Compliance:

In-depth knowledge of global regulatory standards (FDA, EMA, PMDA, TGA, KFDA, NMPA).

Experience in preparing and submitting regulatory documentation for preclinical trials, ensuring compliance with local and international requirements.

4. Tailored Preclinical Services:

Comprehensive in vitro and in vivo studies, including pharmacokinetics (PK), pharmacodynamics (PD), toxicology, and bioanalytical testing.

Expertise in designing customized preclinical studies that align with your specific therapeutic area, whether it’s oncology, autoimmune disorders, or other complex diseases.

5. High-Quality Analytical and Testing Services:

Advanced analytical platforms for comprehensive testing, including HPLC, mass spectrometry, and other cutting-edge technologies.

Robust data analysis and reporting to support decision-making in the drug development process.

6. Collaborative Approach and Personalized Service:

Focused on long-term partnerships, we take a customer-centric approach, aligning our expertise with your project needs.

Dedicated project management and scientific teams ensure smooth communication and efficient execution of each project phase.

Accelerating Drug Development with Precision and Efficiency

At Lianhe Aigen, we understand the complexities of early-stage drug discovery and the critical importance of advancing safe and effective therapies to market. Our CRO services are designed to optimize the drug discovery process, reducing timelines and enhancing the likelihood of success at every stage.

Partner with us to access the most advanced research capabilities and a team of experts dedicated to helping you bring innovative drugs to market faster and more efficiently. Whether exploring new targets, optimizing lead candidates, or preparing for clinical trials, Lianhe Aigen is your trusted CRO partner in the journey to drug development success.